A statement of changes in beneficial ownership was filed on September 11, 2026, disclosing that Mesa Laboratories Inc /CO/ director Jennifer Sadie Alltoft acquired 1,774 restricted stock units on September 9, 2026.

Key Highlights

  • Reporting Person: Jennifer Sadie Alltoft, identified as a Director of Mesa Laboratories Inc /CO/ (NASDAQ:MLAB).
  • Security Acquired: 1,774 Restricted Stock Units, each representing a contingent right to receive one share of the issuer's common stock.
  • Transaction Price: The derivative securities were acquired at a price of $0, according to the filing.
  • Vesting Date: The RSUs vest on September 9, 2027, as noted in the filing's explanation of responses.
  • Beneficial Ownership Following Transaction: 1,774 derivative securities beneficially owned directly following the reported transaction.
  • Filing Agent: The filing was signed by John Sakys under Power of Attorney by Jenny Alltoft, dated September 11, 2026.

Director Share Award at Mesa Laboratories, a Colorado-Based Measurement and Quality Company

According to the filing, Jennifer Sadie Alltoft, who serves as a Director of Mesa Laboratories Inc /CO/, received an award of 1,774 restricted stock units on September 9, 2026. The transaction was reported under Table II, covering derivative securities, and was assigned transaction code "A," indicating an acquisition. Mesa Laboratories, headquartered at 12100 W. 6th Avenue, Lakewood, Colorado, trades on NASDAQ under the symbol MLAB.

The filing explains that each RSU represents a contingent right to receive one share of the issuer's common stock, and that the units vest on September 9, 2027. The price of the derivative security is listed as $0, consistent with a director equity grant rather than a market purchase. Following this transaction, Alltoft directly holds 1,774 derivative securities beneficially, as disclosed in the filing. No non-derivative securities transactions were reported in Table I of the filing.

The filing was submitted pursuant to Section 16(a) of the Securities Exchange Act of 1934, which requires officers, directors, and principal stockholders to disclose changes in beneficial ownership. The issuer is identified in the filing as Mesa Laboratories Inc /CO/, a company that, according to the filing header, is incorporated in Colorado and listed on NASDAQ.

What Was Disclosed

The filing reports the acquisition of 1,774 restricted stock units by director Jennifer Sadie Alltoft of Mesa Laboratories Inc /CO/ (NASDAQ:MLAB) on September 9, 2026, at a price of $0, with vesting scheduled for September 9, 2027.